首页> 外文期刊>Tumor Biology >Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features
【24h】

Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features

机译:缺氧诱导因子-1α和己糖激酶II在胃腺癌中的表达:对预后的影响及其与临床病理特征的关系

获取原文
获取原文并翻译 | 示例
           

摘要

The impact of hypoxia-inducible factor (HIF)-1α and hexokinase-II (HK-II) expression on prognosis of gastric adenocarcinoma patients has not been clearly established. We identified all patients in Cancer Center of Sun Yat-Sen University who were diagnosed as gastric adenocarcinoma and underwent radical gastrectomy between January 1999 and December 2001. We used immunohistochemistry to determine the expressions of HIF-1α protein and HK-II in the surgical sections. We identified 188 patients with gastric adenocarcinoma for the final analysis. The positive rate of HIF-1α and HK-II were 110/188 (54.6%) and 40/188 (21.3%), respectively. Both HIF-1α and HK-II were all positively correlated with tumor size, lower differentiation, and tumor stage. Univariate analysis showed that advanced tumor stages (P < 0.001), tumor size (P = 0.003), HIF-1α expression (P < 0.001), and HK-II expression (P < 0.001) were all significantly associated with shorter survival. The multivariate Cox analysis revealed that tumor stage (P < 0.001), HIF-1α expression (P < 0.001), and HK-II expression (P = 0.002) remained independent prognostic variables for survival. In addition, there was a positive correlation of HIF-1α protein expression and HK-II (P = 0.022). Both HIF-1α and HK-II were overexpressed in gastric adenocarcinoma. The multivariate Cox analysis revealed that both of them were independent factors on survival of gastric adenocarcinoma patients.
机译:尚无明确确定缺氧诱导因子(HIF)-1α和己糖激酶II(HK-II)对胃腺癌患者预后的影响。我们确定了中山大学癌症中心于1999年1月至2001年12月间所有被诊断为胃腺癌并接受了根治性胃切除术的患者。我们使用免疫组化方法确定了手术区域中HIF-1α蛋白和HK-II的表达。 。我们确定了188例胃腺癌患者用于最终分析。 HIF-1α和HK-II的阳性率分别为110/188(54.6%)和40/188(21.3%)。 HIF-1α和HK-II均与肿瘤大小,较低的分化和肿瘤分期呈正相关。单因素分析显示,晚期肿瘤分期(P <0.001),肿瘤大小(P = 0.003),HIF-1α表达(P <0.001)和HK-II表达(P <0.001)与较短的生存期显着相关。多元Cox分析显示,肿瘤分期(P <0.001),HIF-1α表达(P <0.001)和HK-II表达(P = 0.002)仍然是生存的独立预后变量。此外,HIF-1α蛋白表达与HK-II呈正相关(P = 0.022)。 HIF-1α和HK-II在胃腺癌中均过表达。多元Cox分析表明,它们都是胃腺癌患者生存的独立因素。

著录项

  • 来源
    《Tumor Biology》 |2011年第1期|159-166|共8页
  • 作者单位

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

    State Key Laboratory of Oncology in South China Guangzhou 510060 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    HIF-1α; HK-II; Gastric adenocarcinoma; Immunohistochemistry; Survival;

    机译:HIF-1α;HK-II;胃腺癌;免疫组织化学;生存期;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号